View of Comparative Analysis for Reduction in A1c in Dapagliflozin Versus Glimepiride Monotherapy in Non-Obese Type 2 Diabetic Patients

Return to Article Details Comparative Analysis for Reduction in A1c in Dapagliflozin Versus Glimepiride Monotherapy in Non-Obese Type 2 Diabetic Patients Download Download PDF